Tankyrase inhibition promotes endocrine commitment of hPSC-derived pancreatic progenitors

Human pluripotent stem cells (hPSCs) have the potential to differentiate into various cell types, including pancreatic insulin-producing β cells, which are crucial for developing therapies for diabetes. However, current methods for directing hPSC differentiation towards pancreatic β-like cells are often inefficient and produce cells that do not fully resemble the native counterparts. Here, we report that highly selective tankyrase inhibitors, such as WIKI4, significantly enhances pancreatic differentiation from hPSCs. Our results show that WIKI4 promotes the formation of pancreatic progenitors that give rise to islet-like cells with improved β-like cell frequencies and glucose responsiveness compared to our standard cultures. These findings not only advance our understanding of pancreatic development, but also provide a promising new tool for generating pancreatic cells for research and potential therapeutic applications.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2024-10-09
DOI
https://doi.org/10.1038/s41467-024-53068-w
Citations
4
Primary Topic
Pancreatic function and diabetes
Type
article
Field-Weighted Citation Impact
2.29

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tankyrase inhibition promotes endocrine commitment of hPSC-derived pancreatic progenitors

Farida Sarangi, Frankie Poon, Paraish S. Misra, Roman Korytnikov et al.
4 citations
Nature Communications
Pancreatic function and diabetes
2.29
article

Tankyrase inhibition promotes endocrine commitment of hPSC-derived pancreatic progenitors

Farida Sarangi, Frankie Poon, Paraish S. Misra, Roman Korytnikov, M. Cristina Nostro, Amanda Oakie, Rangarajan Sambathkumar, Yasaman Aghazadeh
article en
4 citations

Abstract

Human pluripotent stem cells (hPSCs) have the potential to differentiate into various cell types, including pancreatic insulin-producing β cells, which are crucial for developing therapies for diabetes. However, current methods for directing hPSC differentiation towards pancreatic β-like cells are often inefficient and produce cells that do not fully resemble the native counterparts. Here, we report that highly selective tankyrase inhibitors, such as WIKI4, significantly enhances pancreatic differentiation from hPSCs. Our results show that WIKI4 promotes the formation of pancreatic progenitors that give rise to islet-like cells with improved β-like cell frequencies and glucose responsiveness compared to our standard cultures. These findings not only advance our understanding of pancreatic development, but also provide a promising new tool for generating pancreatic cells for research and potential therapeutic applications.

Nature CommunicationsVol. 15(1)
University Health Network (CA), University of Toronto (CA), Sana Biotechnology (United States) (US), Montreal Clinical Research Institute (CA), McMaster University (CA)
Eli Lilly and Company, Leona M. and Harry B. Helmsley Charitable Trust, Juvenile Diabetes Research Foundation United States of America, Juvenile Diabetes Research Foundation Canada, Toronto General and Western Hospital Foundation, Canadian Society of Transplantation, Eli Lilly Canada, Toronto General Hospital Research Institute, University Health Network, Natural Sciences and Engineering Research Council of Canada, Banting and Best Diabetes Centre, University of Toronto, CIHR Skin Research Training Centre
Zero hunger
Openalex Percentile: Top 11%
Pancreatic function and diabetes
2.29
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.